Another vaccine is now going to be seeking FDA approval.
The Army has announced that they have developed a vaccine that they claim is effective against all variants of COVID and SARS.
Phase one tested the vaccine on unvaxxed and those who had not yet gotten COVID.
Phase two is going to test the vaccine on vaccinated people as well as those who previously had COVID.
After nearly two years, scientists at the Walter Reed Army Institute of Research believe they have developed a vaccine that is effective against all COVID and SARS variants.
Researchers at the Maryland-based facility expect to officially announce the completion of the vaccine in the coming weeks, Defense One first reported.
News of the new super-vaccine comes as the latest COVID variant, Omicron, drives a fresh explosion in cases across the US, just weeks after it was first spotted in a California COVID patient on December 1. It now accounts for 73 per cent of all diagnoses across the country, with the figure as high as 90 per cent in states including New York and New Jersey.
The Army began working on the Spike Ferritin Nanoparticle COVID-19 vaccine (SpFN) in early 2020, with a final release date likely to emerge whenever the Army submits its trial results to the Food and Drug Administration. It also remains unclear whether SpFN will be a single or multiple-shot vaccine.
From the beginning, they worked to create a vaccine that would protect against all existing and potential variants of the viruses.
UPDATE from Jordan Schachtel:
The Army claims they have a safe and effecive vax for all COVID and SARS. This is based on the preliminary results from a stage 1 human trial that has 29 participants. Yes, 29 participants. pic.twitter.com/wgRqngdibB
— Jordan Schachtel @ dossier.substack.com (@JordanSchachtel) December 22, 2021
The Palmieri Report is a Pro-America News Outlet founded by Jacob Palmieri. The Palmieri Report is dedicated to giving people the truth so that they can form their own informed political opinions. You can help us beat Big Tech by following us on GETTR , Telegram, and Rumble.
Listen to our Daily News Podcast!